- Home
- NNVC vs PRPH Comparison
NNVC vs PRPH Comparison
Compare NNVC & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNVC
- PRPH
- Stock Information
- Founded
- NNVC 2005
- PRPH 1989
- Country
- NNVC United States
- PRPH United States
- Employees
- NNVC N/A
- PRPH N/A
- Industry
- NNVC Biotechnology: Pharmaceutical Preparations
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- NNVC Health Care
- PRPH Health Care
- Exchange
- NNVC Nasdaq
- PRPH Nasdaq
- Market Cap
- NNVC 22.5M
- PRPH 15.2M
- IPO Year
- NNVC N/A
- PRPH 1997
- Fundamental
- Price
- NNVC $1.39
- PRPH $0.43
- Analyst Decision
- NNVC
- PRPH
- Analyst Count
- NNVC 0
- PRPH 0
- Target Price
- NNVC N/A
- PRPH N/A
- AVG Volume (30 Days)
- NNVC 238.4K
- PRPH 4.1M
- Earning Date
- NNVC 05-15-2025
- PRPH 08-13-2025
- Dividend Yield
- NNVC N/A
- PRPH N/A
- EPS Growth
- NNVC N/A
- PRPH N/A
- EPS
- NNVC N/A
- PRPH N/A
- Revenue
- NNVC N/A
- PRPH $5,845,000.00
- Revenue This Year
- NNVC N/A
- PRPH $221.82
- Revenue Next Year
- NNVC N/A
- PRPH N/A
- P/E Ratio
- NNVC N/A
- PRPH N/A
- Revenue Growth
- NNVC N/A
- PRPH N/A
- 52 Week Low
- NNVC $0.94
- PRPH $0.22
- 52 Week High
- NNVC $2.55
- PRPH $3.64
- Technical
- Relative Strength Index (RSI)
- NNVC 50.72
- PRPH 62.32
- Support Level
- NNVC $1.34
- PRPH $0.32
- Resistance Level
- NNVC $1.44
- PRPH $0.46
- Average True Range (ATR)
- NNVC 0.09
- PRPH 0.03
- MACD
- NNVC 0.00
- PRPH 0.01
- Stochastic Oscillator
- NNVC 77.14
- PRPH 75.57
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.